Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Phase II Study To Assess Safety and Efficacy With the Renal Assist Device (RAD) In Patients With Acute Renal Failure

NCT00511407 is registered in ClinicalTrials.gov with RenaMed Biologics as lead sponsor.

NCT NCT00511407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00511407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Phase II Study To Assess Safety and Efficacy With the Renal Assist Device (RAD) In Patients With Acute Renal Failure
Lead sponsor
RenaMed Biologics
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2004
Completion date
August 31, 2007
Enrollment
58 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure